20978 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Interferons [IFN]
Human growth hormone modified at position 35
#1202Methods related to immunostimulatory nucleic acid-induced interferon
#1203Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
#1204Vaccine immunotherapy for immune suppressed patients
#1205Methods for treatment of obesity and for promotion of weight loss
#1206Carbon-substituted diketopiperazine delivery systems
#1207Method of treatment using interferon-tau
#1208Methods and compositions for treating hepatitis C virus
#1209Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
#1210Methods and compositions for treating hepatitis C virus
#1211Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
#1212Method of treatment using interferon-tau
#1213Method of treatment using interferon-tau
#1214Composition and dosage form comprising an interferon particle formulation and suspending vehicle
#1215Combination therapy for HCV infection
#1216Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
#1217Iminothiazolidinones as inhibitors of HCV replication
#1218Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
#1219Boroproline compound combination therapy
#1220Combination therapy using interferon-tau
#1221Anti-viral compounds
#1222β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
#1223Receptor recognition factors, protein sequences and methods of use thereof
#1224Use of a polyphenol for the treatment of actinic keratosis
#1225Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#1226Adjuvant agent for hepatitis C
#1227Combination pharmaceutical agents as inhibitors of HCV replication
#1228Pharmaceutical compositions containing plasma protein
#1229Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
#1230Dosing regimen for Flaviviridae therapy
#1231Compositions and methods for the treatment of depression and other affective disorders
#1232Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
#12332′-branched nucleosides and Flaviviridae mutation
#1234Methods and compositions for interferon therapy
#1235Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
#1236Method of preparing biological materials and preparations produced using same
#1237Methods of treatment of neurological diseases by interferon antagonists
#1238Method for delivering interferons to the intradermal compartment
#1239Scar tissue dressing
#1240Interferon-statin combination cancer therapy